| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $53.7M | +4.0% | -0.5% |
| Cost of Revenue | $32.2M | +4.8% | -1.7% |
| R&D Expense | $38.0M | -1.3% | -17.4% |
| SG&A Expense | $20.8M | +13.4% | -0.2% |
| Operating Income | -$38.3M | +10.8% | +23.2% |
| Interest Expense | $4.3M | -4.0% | +99.4% |
| Pre-tax Income | -$41.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $160.9M | -16.5% | +66.0% |
| Accounts Receivable | $53.2M | -10.0% | -5.2% |
| Inventory | $45.6M | -3.0% | -12.5% |
| Current Assets | $297.1M | -10.5% | +23.4% |
| Total Assets | $855.1M | -1.4% | +7.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.8M | — | — |
| Capital Expenditures | $12.6M | — | — |
| Investing Cash Flow | -$30.2M | — | — |
| Financing Cash Flow | -$35.9M | — | — |
| Free Cash Flow | -$55.3M | — | — |
| -0.0% |
| +25.2% |
| Income Tax | -$363K | -164.2% | -15.2% |
| Net Income | -$38.3M | +1.9% | +22.9% |
| EPS (Basic) | -$0.19 | +5.0% | +32.1% |
| EPS (Diluted) | -$0.19 | +5.0% | +32.1% |
| $79.2M |
| +3.5% |
| -21.5% |
| Long-term Debt | $353.5M | +0.3% | +124.4% |
| Total Liabilities | $462.2M | +2.1% | +49.7% |
| Stockholders' Equity | $369.2M | -5.4% | -19.5% |